Serna Bio is an AI-enabled, drug discovery company developing small molecules that modulate translation and splicing challenging-to-drug targets to treat diseases with high unmet medical need.
Enabled by the technological revolutions in synthetic biology, machine learning (ML), and massively multiplexed screening, our platform enables us to rationally design selective, small molecules to target untapped biology.
